• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA UCA1通过影响METTL14的稳定性上调CXCR4和CYP1B1的表达来促进急性髓系白血病的进展。

LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.

作者信息

Li Jiajia, Li Zhongyu, Bai Xue, Chen Xiaofeng, Wang Meng, Wu Yanping, Wu Haotian

机构信息

Department of Hematology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, China.

Bengbu Medical College, Bengbu, Anhui 233030, China.

出版信息

J Oncol. 2022 Feb 8;2022:2756986. doi: 10.1155/2022/2756986. eCollection 2022.

DOI:10.1155/2022/2756986
PMID:35178087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8847036/
Abstract

OBJECTIVE

Increasing numbers of studies have proved that m6A methylation plays crucial roles in different cancers. However, how lncRNA regulates m6A methylation and participates in acute myeloid leukemia (AML) remains unclear. Therefore, this study aims to explore the function and mechanism of UCA1 in AML by regulating m6A methylation.

METHODS

qRT-PCR, western blot, and immunohistochemical staining were used to detect the expression of METTL14, CXCR4, and CYP1B1. qRT-PCR was used to detect the expression of UCA1. CCK8, flow cytometry, and transwell assays were used to detect the proliferation, apoptosis, migration, and invasion of HL60 and U937 cells, respectively. m6A methylation was detected by dot blot analysis. Tumor-bearing mice were established, and tumor weight and volume were analyzed. Immunofluorescence staining, co-localization, and RNA pull-down were used to confirm the reaction between UCA1 and METTL14.

RESULTS

Overexpression of UCA1 promotes AML development . Furthermore, we found that METTL14-influenced m6A methylation could be affected by UCA1. UCA1 promoted AML development by regulating m6A methylation. Moreover, the expression of CYP1B1 and CXCR4 was affected by METTL14. In addition, UCA1 promoted AML development by affecting m6A methylation .

CONCLUSION

In the present study, we demonstrated that lncRNAUCA1 promotes the progression of AML by upregulating the expression of CXCR4 and CYP1B1 by affecting the stability of METTL14.

摘要

目的

越来越多的研究证明,m6A甲基化在不同癌症中发挥着关键作用。然而,长链非编码RNA(lncRNA)如何调节m6A甲基化并参与急性髓系白血病(AML)仍不清楚。因此,本研究旨在通过调节m6A甲基化来探索UCA1在AML中的功能和机制。

方法

采用qRT-PCR、蛋白质免疫印迹法和免疫组织化学染色检测METTL14、CXCR4和CYP1B1的表达。采用qRT-PCR检测UCA1的表达。分别采用CCK8、流式细胞术和Transwell实验检测HL60和U937细胞的增殖、凋亡、迁移和侵袭能力。采用斑点印迹分析检测m6A甲基化。建立荷瘤小鼠模型,并分析肿瘤重量和体积。采用免疫荧光染色、共定位和RNA下拉实验证实UCA1与METTL14之间的相互作用。

结果

UCA1的过表达促进AML的发展。此外,我们发现受METTL14影响的m6A甲基化会受到UCA1的影响。UCA1通过调节m6A甲基化促进AML的发展。此外,CYP1B1和CXCR4的表达受METTL14的影响。此外,UCA1通过影响m6A甲基化促进AML的发展。

结论

在本研究中,我们证明lncRNA UCA1通过影响METTL14的稳定性上调CXCR4和CYP1B1的表达,从而促进AML的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/629c66451fc3/JO2022-2756986.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/60e55df6cc4d/JO2022-2756986.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/eb02451ff618/JO2022-2756986.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/1fb6c1e13d80/JO2022-2756986.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/6395b1fb58ed/JO2022-2756986.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/3f76a9c9aba3/JO2022-2756986.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/7e134b61b3af/JO2022-2756986.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/71fadd6da8b5/JO2022-2756986.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/629c66451fc3/JO2022-2756986.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/60e55df6cc4d/JO2022-2756986.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/eb02451ff618/JO2022-2756986.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/1fb6c1e13d80/JO2022-2756986.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/6395b1fb58ed/JO2022-2756986.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/3f76a9c9aba3/JO2022-2756986.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/7e134b61b3af/JO2022-2756986.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/71fadd6da8b5/JO2022-2756986.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdc/8847036/629c66451fc3/JO2022-2756986.008.jpg

相似文献

1
LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14.长链非编码RNA UCA1通过影响METTL14的稳定性上调CXCR4和CYP1B1的表达来促进急性髓系白血病的进展。
J Oncol. 2022 Feb 8;2022:2756986. doi: 10.1155/2022/2756986. eCollection 2022.
2
MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia.微小 RNA-1306-5p 通过调控 METTL14 指导的 m6A 甲基化抑制急性髓系白血病。
Comput Math Methods Med. 2022 Sep 7;2022:5787808. doi: 10.1155/2022/5787808. eCollection 2022.
3
piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.piRNA-14633 通过 METTL14 依赖性 m6A RNA 甲基化促进宫颈癌恶性进展。
J Transl Med. 2022 Jan 29;20(1):51. doi: 10.1186/s12967-022-03257-2.
4
METTL14-mediated N6-methyladenosine modification of TCP1 mRNA promotes acute myeloid leukemia progression.METTL14 介导的 TCP1 mRNA 的 N6-甲基腺苷修饰促进急性髓系白血病进展。
Cell Signal. 2024 Oct;122:111304. doi: 10.1016/j.cellsig.2024.111304. Epub 2024 Jul 20.
5
LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating mA modification of miR-375 by METTL14 through DNA methylation.长链非编码 RNA UCA1 通过 METTL14 调控 miR-375 的 mA 修饰从而促进乳腺癌中 SOX12 的表达,该过程通过 DNA 甲基化实现。
Cancer Gene Ther. 2022 Jul;29(7):1043-1055. doi: 10.1038/s41417-021-00390-w. Epub 2022 Jan 13.
6
METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.METTL14 通过调控 M6A 甲基化修饰的初级 miR-19a 促进心血管内皮细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):7015-7023. doi: 10.26355/eurrev_202006_21694.
7
LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma.长链非编码RNA RASAL2-AS1在头颈部鳞状细胞癌的增殖和进展中促进METTL14介导的m6A甲基化。
Cancer Cell Int. 2024 Mar 25;24(1):113. doi: 10.1186/s12935-024-03302-8.
8
MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1.MALAT-1 通过促进 ZEB1 的 m6A 修饰来调节 AML 的进展。
Acta Biochim Pol. 2023 Feb 22;70(1):37-43. doi: 10.18388/abp.2020_6017.
9
METTL14 inhibits the malignant processes of gastric cancer cells by promoting N6-methyladenosine (m6A) methylation of TAF10.METTL14通过促进TAF10的N6-甲基腺苷(m6A)甲基化来抑制胃癌细胞的恶性进程。
Heliyon. 2024 May 28;10(11):e32014. doi: 10.1016/j.heliyon.2024.e32014. eCollection 2024 Jun 15.
10
Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.长链非编码 RNA UCA1 通过调节 miR-296-3p/Myc 轴调控急性髓系白血病细胞增殖和凋亡。
Cell Cycle. 2020 Jun;19(12):1454-1465. doi: 10.1080/15384101.2020.1750814. Epub 2020 Apr 14.

引用本文的文献

1
PTCSC3, XIST, GAS5, UCA1, and HIFAL: Five lncRNAs Emerging as Potential Prognostic Players in Egyptian Adult Acute Myeloid Leukemia (AML) Patients.PTCSC3、XIST、GAS5、UCA1和HIFAL:五种长链非编码RNA成为埃及成年急性髓系白血病(AML)患者潜在的预后相关因素。
Cancer Control. 2024 Jan-Dec;31:10732748241309044. doi: 10.1177/10732748241309044.
2
Regulatory RNAs: role as scaffolds assembling protein complexes and their epigenetic deregulation.调控RNA:作为组装蛋白质复合物的支架的作用及其表观遗传失调。
Explor Target Antitumor Ther. 2024;5(4):841-876. doi: 10.37349/etat.2024.00252. Epub 2024 Jul 22.
3
CXCR4 as a therapeutic target in acute myeloid leukemia.

本文引用的文献

1
The essential reading list for AML: the m6A transcripts.急性髓系白血病的必读书目:m6A转录本
Blood. 2021 Jul 8;138(1):6-7. doi: 10.1182/blood.2021011755.
2
N-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation.mRNA 上的 N6-甲基腺苷有助于形成一个液-液相分离的核体,从而抑制髓系白血病的分化。
Cancer Cell. 2021 Jul 12;39(7):958-972.e8. doi: 10.1016/j.ccell.2021.04.017. Epub 2021 May 27.
3
Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).
CXCR4 作为急性髓细胞白血病的治疗靶点。
Leukemia. 2024 Nov;38(11):2303-2317. doi: 10.1038/s41375-024-02326-3. Epub 2024 Sep 11.
4
Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges.解析长链非编码RNA在急性髓系白血病治疗耐药中的作用:新前景与挑战
Noncoding RNA Res. 2024 May 20;9(4):1203-1221. doi: 10.1016/j.ncrna.2024.05.009. eCollection 2024 Dec.
5
Small molecule inhibitors targeting mA regulators.靶向 mA 调控因子的小分子抑制剂。
J Hematol Oncol. 2024 May 6;17(1):30. doi: 10.1186/s13045-024-01546-5.
6
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy.靶向 RNA 修饰的药物治疗:癌症治疗的新前沿。
Cancer Med. 2024 Apr;13(7):e6989. doi: 10.1002/cam4.6989.
7
Emerging role of RNA modification and long noncoding RNA interaction in cancer.RNA 修饰和长非编码 RNA 相互作用在癌症中的新兴作用。
Cancer Gene Ther. 2024 Jun;31(6):816-830. doi: 10.1038/s41417-024-00734-2. Epub 2024 Feb 14.
8
New understandings of the genetic regulatory relationship between non-coding RNAs and mA modification.非编码RNA与mA修饰之间遗传调控关系的新认识。
Front Genet. 2023 Dec 6;14:1270983. doi: 10.3389/fgene.2023.1270983. eCollection 2023.
9
Non-coding RNA-Mediated N6-Methyladenosine (mA) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response.非编码RNA介导的N6-甲基腺苷(m⁶A)沉积:癌症的关键调节因子,影响致癌作用和治疗反应中的关键信号通路。
Noncoding RNA Res. 2023 Nov 13;9(1):84-104. doi: 10.1016/j.ncrna.2023.11.005. eCollection 2024 Mar.
10
Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.西达本胺通过降低 N6-甲基腺苷相关的 GNAS-AS1 抑制急性髓系白血病细胞糖酵解。
Daru. 2024 Jun;32(1):11-24. doi: 10.1007/s40199-023-00482-y. Epub 2023 Nov 6.
长链非编码 RNA HOXA-AS2 通过与 EZH2 结合并抑制急性髓系白血病 (AML) 中的 LATS2 发挥癌基因作用。
Cell Death Dis. 2020 Dec 2;11(12):1025. doi: 10.1038/s41419-020-03193-3.
4
Role of m6A RNA methylation in cardiovascular disease (Review).m6A RNA 甲基化在心血管疾病中的作用(综述)。
Int J Mol Med. 2020 Dec;46(6):1958-1972. doi: 10.3892/ijmm.2020.4746. Epub 2020 Oct 6.
5
Targeting CXCR4 in AML and ALL.靶向急性髓系白血病和急性淋巴细胞白血病中的CXCR4
Front Oncol. 2020 Sep 4;10:1672. doi: 10.3389/fonc.2020.01672. eCollection 2020.
6
High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates mA methylation of MYC mRNA.高 Wilms 瘤 1 相关蛋白表达预测急性髓系白血病不良预后,并调节 MYC mRNA 的 mA 甲基化。
J Cancer Res Clin Oncol. 2021 Jan;147(1):33-47. doi: 10.1007/s00432-020-03373-w. Epub 2020 Sep 3.
7
LNC942 promoting METTL14-mediated mA methylation in breast cancer cell proliferation and progression.LNC942 促进乳腺癌细胞增殖和进展中的 METTL14 介导的 mA 甲基化。
Oncogene. 2020 Jul;39(31):5358-5372. doi: 10.1038/s41388-020-1338-9. Epub 2020 Jun 23.
8
LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155.长链非编码 RNA MEG3 通过海绵吸附 miR-155 正向调控 ALG9 促进急性髓系白血病耐药
Int J Lab Hematol. 2020 Aug;42(4):464-472. doi: 10.1111/ijlh.13225. Epub 2020 May 2.
9
LncRNA NR-104098 Inhibits AML Proliferation and Induces Differentiation Through Repressing EZH2 Transcription by Interacting With E2F1.长链非编码RNA NR-104098通过与E2F1相互作用抑制EZH2转录来抑制急性髓系白血病增殖并诱导分化。
Front Cell Dev Biol. 2020 Mar 26;8:142. doi: 10.3389/fcell.2020.00142. eCollection 2020.
10
Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.长链非编码 RNA UCA1 通过调节 miR-296-3p/Myc 轴调控急性髓系白血病细胞增殖和凋亡。
Cell Cycle. 2020 Jun;19(12):1454-1465. doi: 10.1080/15384101.2020.1750814. Epub 2020 Apr 14.